?cirrhotic

cirrhotic 發(fā)音

英：[s??rɑ?t?k]　　美：[s??r?t?k]

英：　　美：

cirrhotic 中文意思翻譯

cirrhotic 短語(yǔ)詞組

1、cirrhotic gastritis ─── [醫]硬變性胃炎

2、cirrhotic liver disease ─── 肝硬化

3、cirrhotic inflammation ─── [醫]硬變性炎癥：同atrophic inflammation

4、cirrhotic tuberculosis ─── [醫] 閉鎖性肺結核, 非開(kāi)放性肺結核

5、cirrhotic liver ─── [醫] 硬變肝

6、cirrhotic kidney ─── [醫] 硬變腎, 固縮腎, ─── [顆]粒狀腎

7、cirrhotic edema ─── 肝硬化水腫

8、cirrhotic care ─── 肝硬化護理

9、cirrhotic bleed ─── 肝硬化出血

10、cirrhotic nash ─── 肝硬化納什

11、cirrhotic color ─── 肝硬化色

12、biliary cirrhotic liver ─── [醫] 膽汁性肝硬變

cirrhotic 詞性/詞形變化，cirrhotic變形

名詞復數形式:cirrhotics

cirrhotic 相似詞語(yǔ)短語(yǔ)

1、cirrhi ─── 西里

2、cirrhosed ─── 肝硬化

3、diorthotic ─── 二正統的

4、cerotic ─── 銅黃

5、dichotic ─── adj.二重聽(tīng)覺(jué)的

6、cirrhoses ─── n.硬化；肝硬化(cirrhosis的變形)

7、diarrhoetic ─── 腹瀉

8、dicrotic ─── adj.二重脈搏的，重脈的

9、cirrhosis ─── n.硬化；[內科]肝硬化

cirrhotic 常見(jiàn)例句（雙語(yǔ)使用場(chǎng)景）

1、Results There was no significant difference in the level of leptin of the cirrhotic patients and the controls. ─── 結果肝硬化患者血清瘦素水平同對照組相比差異不顯著(zhù)；

2、Study of the Average Grey Scale Values and Color Point Percentage in Normal and Cirrhotic Livers before and after Levovist Enhancement ─── 利聲顯增強前后正常肝和肝硬化平均灰度值和彩點(diǎn)百分比研究

3、cirrhotic liver ─── [醫] 硬變肝

4、Early detection of neuropsychological dysfunction in cirrhotic patients without overt encephalopathy is essential to their prognosis and quality of life. ─── 早期探測肝硬化患者神經(jīng)精神障礙對于患者的預后及提高生活質(zhì)量是很重要的。

5、Effects of preoperative ultraviolet blood irradiation oxygen therapy on cirrhotic patients with hepatocirrhosis portal hypertension ─── 術(shù)前光量子血氧療法對肝硬化門(mén)靜脈高壓癥的影響

6、In this study the appropriate values of sensitivity, specificity and effectiveness of TSA in effusions for cancer and cirrhotic obtained were 88%,90.47% and 89.13% respectively. ─── 以肝硬化組的 TSA+2SD 作為惡性組和肝硬化組的鑒別值,其敏感性為88%,特異性為90.47%,有效性為89.13%。 LSA 則無(wú)鑒別價(jià)值。

7、Abstract ABSTRACT:Objective To research on the main pattern of hepatic cells death during hepatic ischemia/reperfusion(I/R) injury in cirrhotic rat. ─── 摘要 摘要：目的 研究肝硬化大鼠肝缺血再灌注(I/R)損傷時(shí)肝細胞死亡的主要方式。

8、He illustrated his point with a slide of a cross-sectional sample from a cirrhotic liver on which he overlaid biopsy needle placement. ─── 他用一組硬化患者肝穿的橫斷面樣本幻燈解釋示意。

9、So it is recommended that DSCS be employed for the treatment of the lesions of gastric mucosa in case of cirrhotic portal hypertension. ─── DSCS術(shù)后選擇性改善了胃底部的微循環(huán)及功能，對治療粘膜病變有一定意義。

10、Diagnostic value of multi-slice CT angiography in different collateral pathways: pancreatic versus cirrhotic portal hypertension ─── 多層螺旋CT血管成像診斷胰源性與肝硬化門(mén)脈高壓不同側支循環(huán)的價(jià)值

11、The efficacy and safety of a branched-chain amino acids granules in the treatment of cirrhotic hypoproteinemia--A multicenter, randomised, control study ─── 復方支鏈氨基酸顆粒劑治療肝硬化低蛋白血癥多中心臨床觀(guān)察

12、Pericardial devascularization plus endoscopic variceal ligation(EVL) was applied in our hospital as a new union devascularization therapy for 66 cirrhotic portal hypertension patients since 1993. ─── 1993年以來(lái),我院應用賁門(mén)周?chē)茈x斷術(shù)加內鏡下曲張靜脈套扎術(shù)治療門(mén)靜脈高壓癥66例。

13、Methods A control study was performed to compare two cirrhotic groups:25 cases with gallstone(gallstone group),30 cases without gallstone(control group). ─── 方法:采用病例對照研究法,25例肝硬化合并膽石癥患者為膽石組,30例肝硬化無(wú)膽石癥患者為對照組。

14、At the time of first postoperative week, the mean blood glucose value in the 120-minute OGTT in each PAD, PCS and DSCS groups had significant differences compared with the cirrhotic control group (P < 0.05). ─── 術(shù)后第1周DSCS、PAD、PCS組OGTT 120 min血糖值分別為(12.2±2.6)、(12.4±2.8)和(12.6±2.7)mmol/L比肝硬化對照組(9.0±2.4)mmol/L有顯著(zhù)升高;

15、Reduced expression and dynamic alteration of growth hormone receptors in cirrhotic hepatocytes of rats ─── 實(shí)驗性肝硬化肝細胞生長(cháng)激素受體的表達與動(dòng)態(tài)變化

16、Evaluateing prognosis of cirrhotic patients by MELD score combined with serum bilirubin ─── MELD評分聯(lián)合血清膽紅素水平預測肝硬化預后

17、The changes of plasma renin activity in cirrhotic patients with ascites undergoing portacaval shunt ─── 合并腹水的門(mén)靜脈高壓癥患者門(mén)腔靜脈分流術(shù)前后血中腎素活性的變化

18、The cirrhotic process obstructs the intrahepatic portion of the portal venous system. ─── 使門(mén)脈系統的肝內部分受阻。

19、In these cirrhotic patients, the initial presentation of brain abscess may not be fever or leukocytosis , but focal neurologic deficits. ─── 而在這些肝硬化患者中，腦膿瘍剛開(kāi)始的臨床表現可能不是發(fā)燒或白血球上升，而是局部的神經(jīng)學(xué)上缺失。

20、Effects of Nitric Oxide, Interleukin 2 and Interleukin 8 on Portal Hemodynamics of Cirrhotic Patients ─── 一氧化氮與白介素2、8對肝硬化門(mén)脈系統血流量的影響

21、Chu YK, Ma QJ, Liu W, et al.Pathomorphological change in gastric mucosa after liver ischemia reperfusion in cirrhotic rats [J].J Hepatobil Surg, 2003, 11(1): 70-1. ─── [11]褚延魅,馬慶久,劉維,等.肝硬化鼠肝缺血再灌注胃粘膜病理?yè)p傷的研究[J].肝膽外科雜志,2003,11(1):70-1.

22、Endothelium-dependent Relaxation Effect of Rhizoma Al ismatis in Aortic Rings of Liver Cirrhotic Rats ─── 澤瀉對肝硬變大鼠主動(dòng)脈的擴血管作用及機制

23、biliary cirrhotic liver ─── [醫] 膽汁性肝硬變

24、The other component includes metachronous tumors that arise de novo in a preneoplastic cirrhotic liver. ─── 其他成分，包括在腫瘤（發(fā)生）前的硬變肝內出現新形成的異時(shí)腫瘤。

25、Abstract Objective To evaluate the role of nitric oxide(NO) in hyperdynamic circulation in cirrhotic portal hypertension. ─── 摘 要 目的 探討NO在肝硬變門(mén)脈高壓血流動(dòng)力學(xué)中的作用。

26、Methods: The clinical data, the results of bacterial culture and drug sensitivity tests of 108 ascitic specimens from cirrhotic patients with SBP were analyzed retrospectively. ─── 方法：對108例次腹水細菌培養陽(yáng)性肝硬化腹水合并SBP患者的臨床資料以及腹水細菌培養和藥物敏感試驗結果進(jìn)行回顧性分析。

27、Methods The literatures of the recent years on influence of hepatic cirrhotic portal hypertension on liver transplantation were reviewed. ─── 方法對近年來(lái)有關(guān)肝硬變門(mén)靜脈高壓及其合并癥對肝移植的影響的文獻進(jìn)行系統分析。

28、Expression of Growth Hormone Receptor mRNA in Hepatocellular Carcinoma and Matched Para- Cancer Cirrhotic Liver Tissue ─── 生長(cháng)激素受體mRNA在肝細胞癌和癌旁肝硬化組織中的表達

29、Prof.McCullough: Every cirrhotic patient has a loss in protein even if it is undetectable by standard methods clinically. ─── 每位肝硬化患者都存在蛋白質(zhì)過(guò)多的損耗，有時(shí)甚至使用標準臨床方法也檢測不出來(lái)。

30、Methods There were 52 patients including 26 with primary hepatocellular carcinoma and 26 with liver cirrhotic nodules. ─── 方法選取52例患者，其中原發(fā)性肝細胞癌26例，肝硬化結節26例。

31、Influence of Radix Angelicae Sinensis on splanchnic plasma TXA_2 and PGI_2 levels in cirrhotic dog ─── 當歸對膽管結扎肝硬化犬血漿TXA_2/PGI_2水平的影響

32、Portal-azygous devascularization can maintain PVP and PG in portal vein and do not affect liver function of the control rats but it can damage liver cell in cirrhotic rats. ─── 斷流術(shù)能維持PVP及門(mén)脈血PG水平，對正常大鼠肝功能影響小，但對肝硬變大鼠的肝細胞有損害。

33、Abstract： Objective：To observe the protective function of arginine to liver in the cirrhotic rats administrated by TPN. ─── 摘 要： 目的:觀(guān)察精氨酸對肝硬化大鼠全胃腸外營(yíng)養時(shí)的肝保護作用。

34、Perhaps, the authors suggest, the "critically ill cirrhotic" should be a new prognostic stage. ─── 筆者認為，或許“病重肝硬化”應該是一個(gè)新的預后階段。

35、Effect of somatostatin on portal and hepatic hemodynamics and portal venous pressure in cirrhotic patients with portal hypertension ─── 生長(cháng)抑素對肝硬變門(mén)靜脈高壓癥患者門(mén)靜脈、肝靜脈血流和門(mén)靜脈壓力的影響

36、At the time of enrolment, HCC was diagnosed in 20 cirrhotic patients. ─── 在入選登記時(shí)，有20例肝硬化患者被診斷出患有肝細胞癌證。

37、Method 80 cirrhotic patients accepted gastric endoscpy and CT examine,measure the diameter of esophageal varices in the esophageal lumina of CT image. ─── 方法選擇80位肝硬化患者,所有患者均接受胃鏡及食道CT檢查,測量CT圖像下食管腔內曲張食道靜脈直徑。

38、Utsunomiya T,Matsumata T.Metastatic carcinoma in the cirrhotic liver.Am J Surg 1993;166:776 ─── 夏振龍.大腸癌肝轉移的發(fā)生率及臨床特點(diǎn).中國實(shí)用外科雜志1999;19:579

39、Effects of Glypressin on Gastric Mucosal Blood Flow and Vaso-active Substances in Cirrhotic Rats ─── 可利新對肝硬化大鼠胃粘膜血流量及血管活性物質(zhì)的影響

40、The positive rate for both HBV (HBsAg and/or HBcAg) and HCV Ag was also increased in HCC group (14/39,35.89%) compared with cirrhotic group(9/48, 18.75%),but did not reach statistical significance. ─── HBV和HCV抗原同時(shí)陽(yáng)性者在HCC組(14/39,35.89%)高于肝硬化組(9/48,18.7%),但其差別亦達不到統計學(xué)顯著(zhù)性.

41、Objective To analyze the cause of in-hospital death from variceal bleeding in cirrhotic patients with portal hypertension. ─── 摘要目的探討肝硬化門(mén)靜脈高壓癥食管胃底曲張靜脈破裂出血患者住院期間的死亡原因。

42、Objective: To evaluate the efficacy of endoscopic variceal ligation (EVL) combined with partial splenic embolization (PSE) in the treatment of cirrhotic patients with portal hypertension. ─── 摘要目的：探討內鏡靜脈套扎(EVL)和部分性脾栓塞(PSE)聯(lián)合治療肝硬化門(mén)脈高壓癥的效果。

43、CAO ZX, CHEN XP, WU ZD.The changes of immune function af ter hepatectomy for hepatocellular carcinoma in cirrhotic patients[J].Chin J Gen Surg, 2002, 17(6): 328-9. ─── [6]曹志新,陳孝平,吳在德.肝細胞癌合并肝硬化患者肝切除聯(lián)合脾切除的臨床意義探討[J].中華普通外科雜志,2002,17(6):328-9.

44、Expression of nitric oxide synthase in human hepatocellular carcinoma and cirrhotic liver tissue and its clinical significance. ─── 一氧化氮合酶在原發(fā)性肝癌及癌旁肝硬化組織中的表達及其意義。

45、2 Utsunomiya T, Matsumata T. Metastatic carcinoma in the cirrhotic liver. Am J Surg 1993;166:776 ─── 1夏振龍.大腸癌肝轉移的發(fā)生率及臨床特點(diǎn).中國實(shí)用外科雜志1999;19:579

46、Objective: to observe the protective function of arginine to liver in the cirrhotic rats administrated by TPN. ─── 目的：觀(guān)察精氨酸對肝硬化大鼠全胃腸外營(yíng)養時(shí)的肝保護作用。

47、The Clinical Observation of Cirrhotic Portal Hypertension TIPSS Treated and TIPSS with SEEV(Analysis of 84 caes) ─── TIPSS與TIPSS并用SEEV治療肝硬變門(mén)靜脈高壓的臨床觀(guān)察（附84例報告）

48、Methods Seasonal changes of 524 times of upper digestive tract hemorrhage occurring in 370 cases of cirrhotic portal hypertension were retrospectively analyzed. ─── 方法對370例肝炎肝硬化門(mén)脈高壓患者發(fā)生的524例次上消化道出血的四季分布進(jìn)行了回顧性調查。

49、Abstract AIM: To established a rats cirrhotic model by a small dose of endotoxin injection peritoneally and clarify its possible pathogenesis. ─── 摘 要 目的： 觀(guān)察外源性?xún)榷舅卣T發(fā)肝硬化大鼠發(fā)生肝性腦病的可能性及可能機制。

50、Methods The clinical data of variceal bleeding in cirrhotic patients with portal hypertension admitted in recent three years to our hospital were analyzed retrospectively. ─── 方法對近3年收治的186例患者及在住院期內死亡的24例患者的臨床資料進(jìn)行回顧性分析。

51、Effect of eNOS Gene Transfer on the Capacity of Hepatic Sinusoids in cirrhotic rats. ─── eNOS基因治療對肝硬化大鼠肝竇容積的影響

52、18 Mccormic CK PA,Dick R,Siving OS.Octreotide reduce azygos blood flow in cirrhotic patients with portal hypertention. ─── 17張素惠，周建芳.奧曲肽治療老年人食管靜脈曲張破裂出血臨床分析.世界華人消化雜志1999;7：733

53、In conclusion, congestive gastropathy is a common finding in cirrhotic patients.Its appearance is closely correlated with the severity of liver disease. ─── 因此我們的結論是：（1）郁性胃病變常見(jiàn)于肝硬病人且和肝病嚴重程度有關(guān)。

54、Color doppler study of fasting and postprandial hemodynamic changes in hepatic artery and portal vein in cirrhotic patients ─── 彩色多普勒對肝硬化患者入肝血管的血流動(dòng)力學(xué)研究

55、For cirrhotic patients, perhaps you can't stop treatment. ─── 對肝硬化的患者，可能不能停止治療。

56、Materials and methods67 cases of patients with cirrhotic ascites,39 cases with carcinous ascites, 14 cases with tuberculosic ascites were examized ultrasonograhically. ─── 材料與方法通過(guò)對肝硬化腹水67例，癌性腹水39例，結核性腹水14例進(jìn)行觀(guān)察，分析不同原因腹水患者的膽囊、腸管、腹水及腹膜的變化。

57、Patients and methods: Sixty-six patients with fibrotic to cirrhotic hepatitis C virus-related CLD， were consecutively included upon referral to our haemodynamic laboratory. ─── 患者和方法： 推薦到我們的血液動(dòng)力學(xué)實(shí)驗室的連續的66名CLD患者進(jìn)入了本研究，他們是丙肝病毒相關(guān)的肝纖維化或肝硬化的患者。

58、AIM: To established a rats cirrhotic model by a small dose of endotoxin injection peritoneally and clarify its possible pathogenesis. ─── 目的：觀(guān)察外源性?xún)榷舅卣T發(fā)肝硬化大鼠發(fā)生肝性腦病的可能性及可能機制。

59、This lesion should be suspected whenever a cirrhotic patient exhibits unexplained clinical deterioration. ─── 不論何時(shí),凡肝硬變患者一旦出現原因不明的衰弱,都應懷疑肝癌.

60、Keywords Rat Cirrhotic liver Magnetic resonance imaging Magnetization transfer contrast; ─── 大鼠;肝硬化;磁共振成像;磁化傳遞對比;

61、CLINICAL ANALYSIS ON TREATING 46 CASES OF CIRRHOTIC PORTAL HYPERTENTION WITH PROSTAGLANDIN E 1 ─── 前列腺素E_1治療肝硬化門(mén)靜脈高壓癥46例

62、Keywords Bie Jia Jian;Cirrhotic;Liver fibrosis;Bilirubin;Hemoglutination function; ─── 加減鱉甲煎;肝硬化;肝纖四項;膽紅素;凝血功能;

63、Materials and Methods: Ten cirrhotic patients (group A) underwent minor liver resections due to hepatocellular carcinoma (HCC). ─── 方法和材料：10個(gè)肝硬化患者（A組）因為肝細胞癌行肝次全切。

64、Effect of helicobacter pylori infection on hyperdynamic circulatory state and portal hypertensive gastrropathy in liver cirrhotic patients ─── 幽門(mén)螺桿菌感染在肝硬化、肝癌高動(dòng)力循環(huán)及胃黏膜病變中的作用

65、It is also arising in a cirrhotic (nodular) liver. ─── 此病變也可由肝硬化發(fā)展而來(lái)。

66、3 Terg R, Berreta J, Abecasis R, et al. Dextran administration avoids hemodynamie changes following paracentesis in cirrhotic patients. ─── 2貢齊鐵，姚希賢，姜慧卿.排放腹水、靜脈輸注白蛋白對肝硬變患者有效血容量、電解質(zhì)和腎功能的影響.中華消化雜志，1995；15(3)：186

67、Many of the known risk factors for postmenopausal osteoporosis exist in the cirrhotic population, such as excess alcohol intake, steroid use, poor nutrition, and hypogonadism. ─── 尤其那些血色沉著(zhù)病和膽道疾病患者雖無(wú)肝硬化但骨質(zhì)疏松風(fēng)險可能會(huì )更高。

68、Materials and Methods:Cirrhotic patients needed for interventional therapy were assigned into group D (DIPS) and group T (TIPS) randomly. ─── 材料和方法:隨機將需行介入治療的肝硬化門(mén)脈高壓患者分入DIPS(D組)及TIPS(T組)。

69、Expression of nitric oxide synthase in human hepatocellular carcinoma and cirrhotic liver tissue and its clinical significance. ─── 一氧化氮合酶在原發(fā)性肝癌及癌旁肝硬化組織中的表達及其意義。

70、cirrhotic kidney ─── [醫] 硬變腎, 固縮腎, [顆]粒狀腎

71、To Test the value of therapeutic paracentesis, peritoneal lavage and abdominal antibiotic administration in cirrhotic patients with spontaneous bacterial peritonitis(SBP). ─── 為探討腹腔穿刺放液,灌洗及注射抗生素對肝硬化合并自發(fā)性細菌性腹膜炎(SBP)的治療價(jià)值。

72、Prof. McCullough: Every cirrhotic patient has a loss in protein even if it is undetectable by standard methods clinically. ─── 每位肝硬化患者都存在蛋白質(zhì)過(guò)多的損耗，有時(shí)甚至使用標準臨床方法也檢測不出來(lái)。

73、Study on Application of TIPSS in the Treatment of Cirrhotic Portal Hypertension ─── TIPSS治療肝硬化門(mén)脈高壓的應用研究

74、cirrhotic tuberculosis ─── [醫] 閉鎖性肺結核, 非開(kāi)放性肺結核

75、Method 90 Cirrhotic patients with HE were randomly divided into two groups. ─── 方法肝硬化合并肝性腦病90例,隨機分成治療組和對照組。

76、The two other patients were cirrhotic, but had no further identifiable risk factors. ─── 其它兩個(gè)病人有肝硬化，但并未發(fā)現其他危險因素。

77、Methods: Between 1997 and 2006, we selected 45 cirrhotic patients with hepatocellular carcinoma distributed into two groups according to explant histology: MC and Expanded Milan Criteria (EMC). ─── 方法： 1997年至2006年間，我們選定了45名肝硬化肝癌患者，并根據外植體組織學(xué)將其分成兩組：MC組和擴大米蘭標準（EMC）組。

78、Experimental study of applying recombinant human growth hormone to treat cirrhotic rats with ascites ─── 應用重組人生長(cháng)激素治療肝硬化腹水大鼠的實(shí)驗研究

79、Methods Investigate the relationship of the electrolyte's turbulences and ascites levels and hepatic encephalopathy by statistical analysis of 121 cases of cirrhotic Ascites. ─── 方法本文分析總結了肝硬化腹水病人121例，通過(guò)統計學(xué)處理了解電解質(zhì)紊亂與腹水程度、肝性腦病的關(guān)系。

80、Portacaval shunts have been performed for recent variceal hemorrhage in cirrhotic patients without the physician suspecting that a hepatoma was responsible for the portal hypertension. ─── 在肝硬化患者的門(mén)靜脈與腔靜脈的吻合分流處新近出現的靜脈曲張出血癥狀，醫師卻沒(méi)有懷疑到這是肝細胞瘤引起血壓過(guò)度緊張造成的。

81、Methods: A total of 50 cirrhotic patients who underwent both endoscopy and multislice spiral CT within a 4-week interval were prospectively evaluated. ─── 方法：納入肝硬化患者50例，在4周內分別行內鏡和多層螺旋CT檢查。

82、Prognostic evaluation of non-alcoholic cirrhotic patients by means of MELD score combined with HDL-ch levels ─── MELD評分聯(lián)合血清高密度脂蛋白膽固醇水平預測非酒精性肝硬化預后

83、Methods We used a radioimmunoassy to determine serum leptin concentrations in 43 cirrhotic patients with normal renal function and 30 controls matched for gender, age and body mass index(BMI). ─── 方法選擇腎功能正常的43例肝硬化患者和30例與其在性別、年齡和體重指數(BMI)相匹配的對照者，應用放免法測定血清瘦素。

84、Materials and Methods: Percutanous splenic artery DSA was performed in 20 patients with cirrhotic portal hypertension befor operation and 2 years after operation repeetively. ─── 材料與方法：對20例患者于術(shù)前、術(shù)后2年分別行脾動(dòng)脈DSA檢查。

85、As a result, "a patient may be told at one point that he or she has mild disease, only to find out a year later that the liver is cirrhotic," he said. ─── 他用一組硬化患者肝穿的橫斷面樣本幻燈解釋示意。針頭可以穿在一個(gè)位置但是錯過(guò)旁邊的硬化組織，但是只要將針頭移動(dòng)幾個(gè)毫米就檢查到深度硬化的組織。

86、Methods The esophageal varices of 45 cases with cirrhotic patients were treated by endoscopic sclerotherapy with non-water ethanol totalling 96 times. ─── 方法對我院45例肝硬化并發(fā)食管靜脈曲張的患者,在內鏡下用無(wú)水酒精行96次靜脈內注射。

87、Methods Retrospectively analysis were ultrasound findings in 8 patients of Budd-Chiari syndrome and 30 patients of cirrhotic portal hypertension. ─── 方法 回顧性分析8例布加綜合征和30例門(mén)脈性肝硬化患者的超聲影像資料。

88、Effects of erythropoietin or nitric oxide synthesis inhibitor on hyperdynamic circulatory state in cirrhotic rats. ─── 促紅細胞生成素與一氧化氮合酶抑制劑對肝硬化大鼠高動(dòng)力循環(huán)狀態(tài)的影響。

89、The effects of disconnection and shunt procedure on hepatic hemodynamics and function of active cirrhotic patients with portal hypertension ─── 不同術(shù)式對活動(dòng)性肝硬化門(mén)靜脈高壓癥患者肝臟血流動(dòng)力學(xué)和肝功能的影響